High volatility in Viking Therapeutics stock price on Wednesday which ended trading at $94.50

The Viking Therapeutics stock price gained 11.11% on the last trading day (Wednesday, 28th Feb 2024), rising from $85.05 to $94.50. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 14.66% from a day low at $86.70 to a day high of $99.41. The price has risen in 7 of the last 10 days and is up by 208.82% over the past 2 weeks. Volume fell on the last day by -27 million shares and in total, 30 million shares were bought and sold for approximately $2.85 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On Mar 29, 2023, it was reported that BTIG gave VKTX a "Buy" grade with a "hold" action.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $40.72, a level that may pose a second chance to hit a runner.

The Viking Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $51.72 and $30.25. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, January 03, 2024, and so far it has risen 443.10%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

On the downside, the stock finds support just below today's level from accumulated volume at $85.05.With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $12.71 between high and low, or 14.66%. For the last week, the stock has had daily average volatility of 19.13%.

The Viking Therapeutics stock is extremely overbought on RSI14 (97). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Viking Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.